almotriptan NDC 27241-042

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-042Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0042Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-042-21	27241004221	2 BLISTER PACK in 1 CARTON (27241-042-21) / 6 TABLET, FILM COATED in 1 BLISTER PACK (27241-042-68)Marketed from Oct 7, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): almotriptan
Generic name (nonproprietary): almotriptan
Active ingredients: Almotriptan malate — 12.5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Ajanta Pharma USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205523
Marketing start: Oct 7, 2015
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 27241-042_caa5857a-45bf-4b7d-8874-6fe2cb6eb4cfSPL ID caa5857a-45bf-4b7d-8874-6fe2cb6eb4cfSPL set ID 6fa380c4-c885-4743-85bf-88819ae68645RxCUI 284204, 284205UNII PJP312605E
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241004221 followed by a unit qualifier and the quantity

Package 27241-0042-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 31, 2025.

Indications (excerpt from the label)

Almotriptan tablets, USP are 5HT 1B/1D receptor agonist (triptan) indicated for: Acute treatment of migraine attacks in adults with a history of migraine with or without aura ( 1.1 ) Acute treatment of migraine headache pain in adolescents age 12 to 17 years with a history of migraine with or without aura, and who have migraine attacks usually lasting 4 hours or more ( 1.1 ) Important limitations: Use only after a clear diagnosis of migraine has been established ( 1.2 ) In adolescents age 12 to 17 years, efficacy of almotriptan tablets on migraine-associated symptoms was not established ( 1.2 ) Not intended for the prophylactic therapy of migraine ( 1.2 ) Not indicated for the treatment of c…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205523

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205523
Product	Strength	Form · route	Labeler	Product NDC
almotriptan	Almotriptan malate 6.25 mg/1	Tablet, Film coatedOral	Ajanta Pharma USA Inc.	27241-041